The constructs and suggested measures listed here are recommended for
inclusion in clinical treatment trials of late-life depression to opti
mize the return on the significant effort involved in these studies. T
he suggested measures have shown utility in studies documenting outcom
es in depression studies; however the measures listed are by no means
to be interpreted as exhaustive. The authors propose that consistent u
se of a broad set of outcome measures will assist clinicians and polic
ymakers in the identification of appropriate treatments for older, dep
ressed patients.